Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026)
Alto Neuroscience (ANRO) reported Interest & Investment Income of $1.6 million for Q1 2026, down 14.56% on a YoY basis from $1.8 million in Q1 2025, and little changed sequentially from $1.6 million in Q4 2025.
Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 4 years of Interest & Investment Income data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 14.56% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 million (down 30.52% YoY), and the FY2025 full-year result was $6.6 million, down 25.4% from the prior year.
- Interest & Investment Income was little changed at $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.7 million in Q2 2024 to a low of $230000.0 in Q1 2023.
- A 4-year average of $1.5 million and a median of $1.6 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 577.39% in 2024 and tumbled 38.72% in 2025, its largest moves.
- Tracing ANRO's Interest & Investment Income over 4 years: stood at $738000.0 in 2023, then surged by 189.3% to $2.1 million in 2024, then fell by 26.89% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
- Business Quant data shows ANRO's Interest & Investment Income at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 738,000.00 |
| Sep 30, 2023 | 714,000.00 |
| Jun 30, 2023 | 667,000.00 |
| Mar 31, 2023 | 230,000.00 |